"Long acting muscarinic antagonist" trang 1 - tải miễn phí từ tailieunhanh
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: The GLOW5 study

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: The GLOW5 study
11    30    1
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: A post hoc subgroup analysis

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: A post hoc subgroup analysis
10    29    1
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease

A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
8    31    1
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: A database study

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: A database study
9    40    1
Dose response of umeclidinium administered once or twice daily in patients with COPD: A randomised cross-over study

Dose response of umeclidinium administered once or twice daily in patients with COPD: A randomised cross-over study
14    22    1
Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease
10    22    1
Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: Analysis of two Phase I, randomised, double-blind, placebo-controlled studies

Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: Analysis of two Phase I, randomised, double-blind, placebo-controlled studies
13    35    1
Treatment with LABA versus LAMA for stable COPD: A systematic review and meta-analysis

Treatment with LABA versus LAMA for stable COPD: A systematic review and meta-analysis
11    45    1
Prognostic and functional impact of perioperative LAMA/LABA inhaled therapy in patients with lung cancer and chronic obstructive pulmonary disease

Prognostic and functional impact of perioperative LAMA/LABA inhaled therapy in patients with lung cancer and chronic obstructive pulmonary disease
11    52    3